DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,247 | +10.1% | 2,645,099 | +6.5% | 0.41% | +8.5% |
| Q2 2023 | $596,179 | +41.6% | 2,484,072 | +48.7% | 0.38% | +95.3% |
| Q1 2023 | $420,935 | -23.9% | 1,670,107 | -19.9% | 0.19% | -22.2% |
| Q4 2022 | $553,463 | -99.9% | 2,085,250 | -8.7% | 0.25% | -61.5% |
| Q3 2022 | $590,016,000 | +22.2% | 2,284,308 | +20.0% | 0.64% | +118.3% |
| Q2 2022 | $482,720,000 | -28.5% | 1,904,067 | -17.3% | 0.30% | -44.2% |
| Q1 2022 | $675,564,000 | -68.2% | 2,303,082 | -64.3% | 0.53% | +33.6% |
| Q4 2021 | $2,122,780,000 | +201.9% | 6,452,014 | +179.3% | 0.40% | +25.3% |
| Q3 2021 | $703,229,000 | +40.6% | 2,309,905 | +23.9% | 0.32% | +33.9% |
| Q2 2021 | $500,244,000 | +30.3% | 1,864,082 | +9.3% | 0.24% | +14.6% |
| Q1 2021 | $383,869,000 | +13.6% | 1,705,469 | +12.1% | 0.21% | +15.7% |
| Q4 2020 | $337,961,000 | -37.6% | 1,521,394 | -39.5% | 0.18% | -44.5% |
| Q3 2020 | $541,225,000 | +125.0% | 2,513,470 | +84.7% | 0.32% | +72.6% |
| Q2 2020 | $240,574,000 | -6.0% | 1,360,492 | -26.4% | 0.19% | -8.4% |
| Q1 2020 | $255,995,000 | -2.9% | 1,849,541 | +7.6% | 0.20% | +39.0% |
| Q4 2019 | $263,750,000 | +12.4% | 1,718,461 | +5.7% | 0.15% | -0.7% |
| Q3 2019 | $234,733,000 | +1.2% | 1,625,235 | +0.2% | 0.15% | +3.5% |
| Q2 2019 | $231,911,000 | +20.5% | 1,622,662 | +11.3% | 0.14% | +6.8% |
| Q1 2019 | $192,510,000 | +15.1% | 1,458,174 | -10.1% | 0.13% | +3.1% |
| Q4 2018 | $167,290,000 | -10.4% | 1,622,312 | -5.6% | 0.13% | 0.0% |
| Q3 2018 | $186,749,000 | +14.0% | 1,718,653 | +3.6% | 0.13% | -7.9% |
| Q2 2018 | $163,777,000 | -10.9% | 1,659,704 | -11.6% | 0.14% | 0.0% |
| Q1 2018 | $183,877,000 | +16.8% | 1,878,031 | +10.7% | 0.14% | +8.5% |
| Q4 2017 | $157,460,000 | +51.1% | 1,696,384 | +39.6% | 0.13% | +19.4% |
| Q3 2017 | $104,207,000 | +14.9% | 1,214,825 | +13.0% | 0.11% | +11.3% |
| Q2 2017 | $90,708,000 | -1.1% | 1,074,849 | +0.2% | 0.10% | -3.0% |
| Q1 2017 | $91,742,000 | +13.4% | 1,072,610 | +3.2% | 0.10% | +13.6% |
| Q4 2016 | $80,934,000 | +57.2% | 1,039,758 | +58.3% | 0.09% | +51.7% |
| Q3 2016 | $51,489,000 | -19.5% | 656,863 | +3.8% | 0.06% | -30.1% |
| Q2 2016 | $63,942,000 | +32.9% | 633,080 | +23.7% | 0.08% | +13.7% |
| Q1 2016 | $48,119,000 | -44.8% | 511,891 | -46.0% | 0.07% | -31.1% |
| Q4 2015 | $87,136,000 | +33.5% | 947,113 | +23.3% | 0.11% | +35.9% |
| Q3 2015 | $65,286,000 | -82.6% | 768,021 | -82.6% | 0.08% | -81.5% |
| Q2 2015 | $374,944,000 | +246.7% | 4,411,016 | +242.6% | 0.42% | +236.8% |
| Q1 2015 | $108,148,000 | -49.2% | 1,287,489 | -48.6% | 0.12% | -39.0% |
| Q4 2014 | $212,943,000 | +62.3% | 2,505,140 | +43.3% | 0.20% | +62.7% |
| Q3 2014 | $131,167,000 | +67.6% | 1,748,724 | +74.3% | 0.13% | +51.8% |
| Q2 2014 | $78,267,000 | +9.3% | 1,003,393 | +5.1% | 0.08% | +2.5% |
| Q1 2014 | $71,585,000 | -8.6% | 954,395 | -6.2% | 0.08% | 0.0% |
| Q4 2013 | $78,360,000 | +43.2% | 1,017,606 | +28.4% | 0.08% | +22.7% |
| Q3 2013 | $54,705,000 | +53.7% | 792,806 | +41.0% | 0.07% | +50.0% |
| Q2 2013 | $35,581,000 | – | 562,114 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |